Gayle Stirling Jameson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Publications & Presentations
PubMed
- 17 citationsSurvival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations o...Li-Tzong Chen, Jens T. Siveke, Andrea Wang-Gillam, Chung Pin Li, György Bodoky
European Journal of Cancer. 2018-12-01 - A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patientsRamesh K. Ramanathan, Glen J. Weiss, Richard G. Posner, N. V. Rajeshkumar, Gayle S. Jameson
Journal of Gastrointestinal Oncology. 2017-12-01 - 107 citationsCorrelation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot StudyRamesh K. Ramanathan, Ronald L. Korn, Natarajan Raghunand, Jasgit C. Sachdev, Ronald G. Newbold
Clinical Cancer Research. 2017-07-15
Office
10510 N 92nd St
Suite 200
Scottsdale, AZ 85258Phone+1 480-323-1353Fax+1 480-323-1359
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
